Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	107.39	90.44	43.61
Graham Fair Price	-55.80	1.70	3.84
PEG	35.91	1.65	1.21
Price/Book	-2.78	2.54	2.62
Price/Cash Flow	51.52	72.44	47.81
Prices/Earnings	395.79	-198.50	40.04
Price/Sales	16.37	13.63	11.71
Price/FCF	51.52	72.44	47.81
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	71.78	0.49	0.28
Operating Margin	-97.05	< 0.005	0.15
ROA	-80.38	< 0.005	< 0.005
ROE	0.02	< 0.005	-80.39
ROIC	0.02	< 0.005	-98.15
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-85.50
Dividends QOQ	0.00	-0.79	-100.00
EBIT QOQ	0.27	-1.02	285.49
EPS QOQ	0.33	-1.20	264.78
FCF QOQ	0.84	-0.36	-57.65
Revenue QOQ	0.01	-0.16	1391.64
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-1.23	0.14	-88.67
Days Sales Outstanding (DSO)	65.05	69.90	7.46
Inventory Turnover	-73.18	645.87	782.61
Debt/Capitalization	0.38	0.38	0.60
Quick Ratio	4.26	4.05	-4.90
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.33	6.32	-0.18
Cash	1.51	1.71	13.62
Capex	-0.05	-0.04	9.59
Free Cash Flow	0.35	0.22	-35.96
Revenue	1.41	1.18	-16.61
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.39	4.29	-2.45
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.66	11.08	95.81
Naive Interpretation	Member

06 - Financial Health · Bad

Rating